ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives
ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business
2026-11-05
$71.47
+ 1.48 (2.11%)
Pricing delayed by 20 minutes
Last updated
2026-11-18 16:00:00